Eli Lilly and Company
$1,417.54+$43.84 (+3.19%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 2.22% below the high.
OTC · ROIX · USD
Stock price
Quote as of May 15, 2023, 07:31 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Response Oncology, Inc., originally incorporated in Memphis, Tennessee, in 1984, has largely ceased its business activities and no longer maintains significant operations. By May 20, 2002, the company had completed the liquidation of most of its operating assets, with the expectation that all remaining assets would be sold and wind-down procedures finalized by the end of that year. Historically, the company functioned as a comprehensive cancer management firm, providing advanced cancer treatment through its outpatient IMPACT Centers, overseeing the non-medical aspects of oncology practices, compounding and dispensing pharmaceuticals to specific oncologists, and conducting outcomes research for pharmaceutical manufacturers.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:44 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$1,417.54+$43.84 (+3.19%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 2.22% below the high.
$273.20-$2.00 (-0.73%)
Johnson & Johnson’s quoted price sits in the upper half of its reported 52-week range, 3.12% below the high.
$0.00-$0.00 (-50.0%)
The Greenrose Holding Company Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00-$0.00 (-90.0%)
LifeHOUSE Holdings, LLC’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
$0.00$0.00 (0.0%)
Refocus Group, Inc.: Healthcare · Medical - Devices.
$0.00$0.00 (0.0%)
QMed, Inc.: Healthcare · Medical - Specialties.
$0.00-$0.08 (-100.0%)
Synvista Therapeutics, Inc.: Healthcare · Medical - Pharmaceuticals.
$0.00$0.00 (0.0%)
VeriTeQ Corporation: Healthcare · Medical - Instruments & Supplies.